TY - JOUR
T1 - SCN5A-1795insD founder variant
T2 - a unique Dutch experience spanning 7 decades
AU - Proost, Virginnio M.
AU - van den Berg, Maarten P.
AU - Remme, Carol Ann
AU - Wilde, Arthur A. M.
N1 - Funding Information: This work was supported by the Netherlands CardioVascular Research Initiative CVON (Dutch Heart Foundation, Dutch Federation of University Medical Centres, Netherlands Organisation for Health Research and Development (ZonMw) and Royal Netherlands Academy of Sciences (project CVON2018-30 PREDICT2 for C. A. Remme and A. A. M. Wilde and project CVON2015-12 eDETECT for M. P. van den Berg and C. A. Remme)). C. A. Remme and A. A. M. Wilde have received a European Joint Research Programme on Rare Diseases grant for the project ‘SILENCE-LQTS’. Publisher Copyright: © 2023, The Author(s).
PY - 2023/8
Y1 - 2023/8
N2 - The SCN5A-1795insD founder variant is a unique SCN5A gene variant found in a large Dutch pedigree that first came to attention in the late 1950s. To date, this is still one of the largest and best described SCN5A founder families worldwide. It was the first time that a single pathogenic variant in SCN5A proved to be sufficient to cause a sodium channel overlap syndrome. Affected family members displayed features of Brugada syndrome, cardiac conduction disease and long QT syndrome type 3, thus encompassing features of both loss and gain of sodium channel function. This brief summary takes us past 70 years of clinical experience and over 2 decades of research. It is remarkable to what extent researchers and clinicians have managed to gain understanding of this complex phenotype in a relatively short time. Extensive clinical, genetic, electrophysiological and molecular studies have provided fundamental insights into SCN5A and the cardiac sodium channel Nav1.5.
AB - The SCN5A-1795insD founder variant is a unique SCN5A gene variant found in a large Dutch pedigree that first came to attention in the late 1950s. To date, this is still one of the largest and best described SCN5A founder families worldwide. It was the first time that a single pathogenic variant in SCN5A proved to be sufficient to cause a sodium channel overlap syndrome. Affected family members displayed features of Brugada syndrome, cardiac conduction disease and long QT syndrome type 3, thus encompassing features of both loss and gain of sodium channel function. This brief summary takes us past 70 years of clinical experience and over 2 decades of research. It is remarkable to what extent researchers and clinicians have managed to gain understanding of this complex phenotype in a relatively short time. Extensive clinical, genetic, electrophysiological and molecular studies have provided fundamental insights into SCN5A and the cardiac sodium channel Nav1.5.
KW - Brugada Syndrome
KW - Cardiac conduction disease
KW - LQT3
KW - Overlap syndrome
KW - SCN5A
KW - Sudden cardiac death
UR - http://www.scopus.com/inward/record.url?scp=85165206446&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s12471-023-01799-8
DO - https://doi.org/10.1007/s12471-023-01799-8
M3 - Review article
C2 - 37474841
SN - 1568-5888
VL - 31
SP - 263
EP - 271
JO - Netherlands heart journal
JF - Netherlands heart journal
IS - 7-8
ER -